Research Article
Transforming Growth Factor-β1 Gene Polymorphism (T29C) in Egyptian Patients with Hepatitis B Virus Infection: A Preliminary Study
Table 2
Genotype and allelic frequencies of the TGF-β1 T29C in patients with hepatitis B and healthy controls.
| | SNP | HBV group
() | Control group
() | P | OR (95% CI) |
| | Genotype frequency (N, %) | | T/T | 11 (16.9%) | 12 (44.4%) | | 0.2546 (0.0938–0.6910) | | T/C | 44 (67.7%) | 15 (55.6%) | NS | 1.6762 (0.6680–4.2062) | | C/C | 10 (15.4%) | 0 (0.0%) | | 10.4054 (0.5878–184.1951) | | TCCC | 54 (83.1%) | 15 (55.6%) | | 3.2000 (1.1697–8.7541) |
| | Allele frequency | | T | 66 (84.6%) | 39 (92.6%) | NS | 0.3966 (0.1994–0.7889) | | C | 64 (83.1%) | 15 (55.6%) | | 2.5212 (1.2676–5.0147) |
|
|
